Create
Query
event_store.db
—
signals
actions
agent_runs
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
intel_memory
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_97233d3cd8c9 in signals
id
sig_97233d3cd8c9
Primary key.
TEXT
event_id
128723
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_sec_filing_delta
TEXT NOT NULL
value
{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","company":"Viridian Therapeutics, Inc.\\DE","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","article_chars":1964,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_c275815294afddef","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:19:59.131994+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"DEFA14A","final_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","source_event_id":"evt_87466dad76c5","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"6814e3ce280c9a73","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","June 2, 2026","May 19, 2026"],"entities":[{"asset_class":"equity","name":"Viridian Therapeutics, Inc.","relevance":"high","symbol":"","type":"issuer"}],"event_type":"listing","information_gaps":["No specific proxy proposals, resolutions, or voting items are included in the provided text (only an overview/availability notice).","The filing\u2019s \u201cAmendment No.\u201d value is blank in the provided text.","No prior known state is provided in the prompt, so the exact delta vs prior filings cannot be determined from the supplied content."],"key_facts":["The document is a Schedule 14A information statement (proxy statement) under Section 14(a) of the Securities Exchange Act of 1934.","The filing indicates it is filed by the registrant (\u2612 Filed by the Registrant).","The notice states the stockholder meeting will be held on June 2, 2026.","The notice states stockholders can view the proxy statement, notice, and annual report online or request free paper/email copies.","The notice states requests for paper/email copies must be made prior to May 19, 2026.","The notice provides access/request methods: www.ProxyVote.com, call 1-800-579-1639, or email sendmaterial@proxyvote.com (with a control number in the subject line).","The notice states: \u201cTHIS IS NOT A VOTABLE BALLOT\u201d and that it is only an overview of more complete proxy materials."],"numeric_claims":[{"label":"Annual meeting date","value":"June 2, 2026"},{"label":"Request deadline for paper/email copies","value":"May 19, 2026"}],"primary_claim":"Viridian Therapeutics, Inc. filed Form DEFA14A (Schedule 14A information) on 2026-04-17, with proxy materials for a stockholder meeting scheduled for June 2, 2026.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Viridian Therapeutics, Inc. filed a Schedule 14A proxy-related filing (DEFA14A) providing notice of the availability of proxy materials for a stockholder meeting. The notice states the annual meeting will be held on June 2, 2026 and describes how to access or request the proxy materials.","topics":["SEC filing","proxy statement","Schedule 14A","stockholder meeting notice","proxy materials availability"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 Viridian Therapeutics, Inc.\\DE \u00b7 Filed 20260417","ticker":"VRDN","tickers":["VRDN"],"title":"VRDN filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_sec_filings
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_87466dad76c5"]}
TEXT
dedupe_key
signal_enriched:discovery_sec_filing_delta:7d155fef3e449ce3
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-18T03:05:05.644967+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel